An apple a day keeps the doctor away. Here’s a new health-related adage to consider: Regular consumption of marijuana keeps you thin and active.

According to researchers at Oregon Health and Science University, people who use marijuana more than five times per month have a lower body mass index (BMI) than people who do not marijuana.

The researchers concluded:

“Heavy users of cannabis had a lower mean BMI compared to that of never users, with a mean BMI being 26.7 kg/m in heavy users and 28.4 kg/m in never users.”

It is now illegal to have any type of marijuana, even medical marijuana, at the Orlando International Airport.

The Greater Orlando Aviation Authority Board unanimously approved the medical marijuana ban Wednesday.

A draft policy published this week by the Greater Orlando Aviation Authority puts medical marijuana users at risk of arrest when flying out of Orlando International Airport, despite 71 percent of Florida voters choosing to legalize weed for medical uses last November. 

Understanding the cannabis consumer is a hard, but undeniably important, job. In an industry growing at such a rapid pace to meet an unprecedented level of demand, cannabis industry professionals are looking for consumer-level data more than ever.

It’s important to understand why a person is consuming cannabis to understand how to create and market a product that directly speaks to their wants and needs.

Like many medical marijuana patients across the country right now, DeAnna Bigoni is afraid. 

Four years after she started growing and making her own cannabis products to fight a years-long dependence on opioid painkillers, the Washington resident is afraid the Trump administration will take those rights away.

In September last year, Muttley's human parents Tim* and Tina* got the worst news possible. Their beloved 12 year-old American staffordshire terrier cross was dying.

Alberta's latest cannabis growers said Tuesday they remain bullish about the nascent industry despite a major sell-off of pot stocks that has sent share prices tumbling for months.

After submitting its application for a production license four years ago, Airdrie's Sundial Growers secured Health Canada's approval last week, becoming the third legal producer of medical marijuana in Alberta.

The facility west of Airdrie is relatively small for the industry, at 30,000 square feet, but the company plans to break ground in the coming weeks on a $120-million grow-op spanning 400,000 square feet in the central Alberta town of Olds.

With cannabis legalization on the horizon next year, the federal government must make it easier to study the potential medical benefits of the drug and evaluate how ending prohibition might affect society, according to an open letter to politicians from dozens of the country’s leading academics and public-health researchers who study the drug.

“Under widespread global prohibition, cannabis research has been limited by the criminalization and stigmatization of cannabis use and users, leading to substantial gaps in knowledge around the harms and benefits of both medical and non-medical cannabis,” reads a letter sent Monday to federal lawmakers on the letterhead of the BC Centre on Substance Use, an organization funded by the provincial government to study drugs.

There is much talk in medical circles about the use of medical marijuana (or cannabis) for a variety of chronic illnesses, but could it also benefit those living with chronic lung disease?

Medical marijuana is currently legal in 23 states in the U.S., as well as Washington, D.C., but its use is a contentious issue with as many people for it as are against it.

If illicit pot plants flourishing covertly in the Colombian countryside represent the marijuana industry’s past, then Canada’s commercial-scale medical licensing system represents its future.

PharmaCielo Ltd., a privately held medical marijuana producer with global ambitions, is hoping to capitalize on both those traditions.

The company, which has board members from U.S. big tobacco and big pharma, is headquartered in Canada — a decision made due to this country’s sophisticated medical cannabis regulations, friendly financial markets and growing base of accountants, lawyers and bankers with cannabis expertise.

This summer, the Uk’s first medical cannabis research facility is going to open – studying the medical uses of weed for the first time in this country.

Do they need any volunteers, we wonder?

The facility will be opened by Medipen – who tested a cannabis vaporiser with the NHS last year.

The Medipen contains ‘cannabidiol’ (CBD), a chemical from cannabis which campaigners claim helps with diseases including cancer and Crohn’s disease.

Crucially, the oil doesn’t contain any THC, the chemical in cannabis which causes the high – and it is legal in the UK.

But in the new facility – at an as-yet-undisclosed location – will explore the use of THC (the chemical in cannabis which gets you stoned) as a treatment for cancer patients.